COMMUNIQUÉS West-GlobeNewswire

Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region

31/01/2018 - 03:01

DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE: MDT ) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's Minimally Invasive [...]

MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California

31/01/2018 - 00:00

LA JOLLA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

National Research Corporation to Broadcast its 2017 Fourth Quarter and Year-End Conference Call Live on the Internet

30/01/2018 - 23:59

Lincoln, Nebraska, Jan. 30, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced that it will provide an online web simulcast of its 2017 fourth quarter and year-end [...]

Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals

30/01/2018 - 23:51

VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States

30/01/2018 - 22:47

HOUSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Avinger Announces Reverse Stock Split

30/01/2018 - 22:45

REDWOOD CITY, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will effect a 1- [...]

Vistin Pharma ASA : Vistin Pharma to postpone the expansion of the metformin production capacity

30/01/2018 - 22:38

Oslo, Norway, 30 January 2018 Norwegian pharmaceutical company Vistin Pharma ASA announced today that it has decided to postpone the construction of the new NOK 120 million production line at the Company's dedicated [...]

Vical Announces Restructuring to Focus Resources on HSV-2 and Antifungal Clinical Programs

30/01/2018 - 22:15

SAN DIEGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced a restructuring to conserve capital and to focus its efforts on VL-2397, its antifungal drug product candidate which is [...]

Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option

30/01/2018 - 22:05

CAMBRIDGE, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) (the “Company” or “SLDB”), announced today the closing of its initial public offering of 8,984,375 shares of its common stock, [...]

Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology

30/01/2018 - 22:03

SHENZHEN, CHINA and NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, today announced the State [...]

AveXis to Initiate Screening for Remaining Patients in Pivotal Trial of AVXS-101 for SMA Type 1 Following Review of Preliminary Data from First Three Patients

30/01/2018 - 22:01

CHICAGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

30/01/2018 - 22:01

BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging- [...]

Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility

30/01/2018 - 22:01

SANTA BARBARA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today provided an update on its pre-market approval (PMA) supplement for [...]

FOR IMMEDIATE RELEASE: The importance of mental health literacy among all of the awareness

30/01/2018 - 21:20

HALIFAX, Nova Scotia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Today our media feeds will be filled with support for mental illness and it will feel like awareness is high, but awareness alone is not enough. “While mental [...]

Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition

30/01/2018 - 20:13

Washington, DC, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In its response to the U.S. Department of Health and Human Services’ latest Request for Information on Promoting Health Care Choice and Competition Across the United [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2017

30/01/2018 - 18:01

Communiqué de presse Villepinte, le 30 janvier 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Invitation to Idorsia's full year results 2017 webcast and conference call

30/01/2018 - 17:40

Idorsia will publish its full year financial results 2017 on Tuesday 6 February 2018 at 07:00 CET. An investor conference call and webcast will be held to discuss the results on the same day at 14:00 CET / 13:00 GMT / [...]

CORRECTING and REPLACING -- Innovate Biopharmaceuticals Announces Successful Merger Completion

30/01/2018 - 17:30

RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) please note that the stock symbol for Monster Digital, Inc [...]

Vaccinex, Inc. to Host Key Opinion Leader Luncheon on Huntington’s Disease

30/01/2018 - 17:14

ROCHESTER, N.Y., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other [...]